134 related articles for article (PubMed ID: 37285094)
1. ASO Author Reflections: Intramural Metastasis as Dismal Prognostic Factor in Esophageal Squamous Cell Carcinoma.
Ushimaru Y; Makino T; Doki Y
Ann Surg Oncol; 2023 Aug; 30(8):5203-5204. PubMed ID: 37285094
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: The Role of Skeletonizing en bloc Esophagectomy in Esophageal Squamous Cell Carcinoma.
Kim DJ; Kim HE
Ann Surg Oncol; 2022 Aug; 29(8):4918-4919. PubMed ID: 35419759
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Using Efficacy Index to Clarify the Clinical Value of Each Lymph Node Station for Esophageal Squamous Cell Carcinoma.
Nie X; Li K; Peng L; Leng X
Ann Surg Oncol; 2023 Sep; 30(9):5866-5867. PubMed ID: 37322279
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Nodal Skip Metastasis Is Associated with Survival Benefit in Thoracic Esophageal Squamous Cell Carcinoma.
Yang YS; Shang QX; Yuan Y; Chen LQ
Ann Surg Oncol; 2021 Oct; 28(11):6353-6354. PubMed ID: 33543386
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Additional Esophagectomy After Noncurative Endoscopic Resection Versus Upfront Esophagectomy in Patients with T1N0 Esophageal Squamous Cell Carcinoma.
Maruyama S; Okamura A; Watanabe M
Ann Surg Oncol; 2021 Sep; 28(9):4867-4868. PubMed ID: 33492541
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.
Deng W; Chen J; Xiao Z
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):802-803. PubMed ID: 31654164
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Esophageal Squamous Cell Carcinoma-Still a Conundrum.
Squires MH; Salo JC
Ann Surg Oncol; 2022 Feb; 29(2):1334-1335. PubMed ID: 34674090
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Prognostic Role of a Coagulation Index for Patients with Esophageal Squamous Cell Cancer.
Wang Q; Cao B; Mi K
Ann Surg Oncol; 2021 Dec; 28(13):8462-8463. PubMed ID: 34106387
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Treatment Strategies for Locally Advanced Borderline Resectable Esophageal Squamous Cell Carcinoma.
Hong Y
Ann Surg Oncol; 2024 Feb; 31(2):896. PubMed ID: 37962739
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatment.
Sugiyama F; Kanda M; Kodera Y
Ann Surg Oncol; 2024 May; 31(5):3473-3474. PubMed ID: 38261127
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: The Lymph Node Ratio is an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy.
Kitamura Y; Oshikiri T
Ann Surg Oncol; 2021 Aug; 28(8):4529. PubMed ID: 33399999
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: A Novel Station-Based Nodal Staging System for Esophageal Squamous Cell Carcinoma.
Yuan Y; Hong HG; Chen LQ
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):782-783. PubMed ID: 31605350
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Serine Protease 27 is a Novel Prognostic Indicator for Esophageal Squamous Cell Carcinoma with Preoperative Treatment.
Kataoka A; Yamada K; Kawamura YI
Ann Surg Oncol; 2021 Sep; 28(9):5382-5383. PubMed ID: 33454876
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Safety of Elective Esophagectomy Performed on Weekend for Patients with Esophageal Carcinoma.
Yang TY; Chao YK
Ann Surg Oncol; 2023 Jun; 30(6):3799. PubMed ID: 36905439
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma.
Matsuda S; Kawakubo H; Okamura A; Takahashi K; Toihata T; Takemura R; Mayanagi S; Takeuchi H; Watanabe M; Kitagawa Y
Ann Surg Oncol; 2021 Dec; 28(13):8448-8449. PubMed ID: 34143335
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Supraclavicular Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma.
Park SY; Lee J; Jeon YJ; Cho JH; Kim HK; Choi YS; Zo JI; Shim YM
Ann Surg Oncol; 2024 Mar; 31(3):1583-1584. PubMed ID: 38190057
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Prognostic Significance of Kallikrein-Related Peptidase 13 Induction After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Shimomura A; Yamada K; Kawamura YI
Ann Surg Oncol; 2024 Jan; 31(1):243-244. PubMed ID: 37851200
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma?
Suzuki T; Okamura A; Watanabe M; Chin K
Ann Surg Oncol; 2020 May; 27(5):1518-1519. PubMed ID: 32108921
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: NADPH Oxidase 2 has Potential as a Therapeutic Target for Esophageal Squamous Cell Carcinoma.
Shimizu H; Katsurahara K; Inoue H; Shiozaki A; Otsuji E
Ann Surg Oncol; 2022 Dec; 29(13):8688-8689. PubMed ID: 35986132
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Optimizing Proximal Esophageal Squamous Cell Carcinoma Treatment.
Patel DC; Berry MF
Ann Surg Oncol; 2023 Feb; 30(2):828-829. PubMed ID: 36258059
[No Abstract] [Full Text] [Related]
[Next] [New Search]
